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Monday, February 4, 2013 309athe interactions via the myosin tails are strong enough to maintain overall struc-
tural integrity. The electrostatically modulated TF compaction may contribute
towards structural dynamics necessary for interactions with various sarcomeric
proteins.
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Myosin binding protein-C (MyBP-C) is a thick filament accessory protein of
vertebrate striated muscle. It is essential for normal cardiac function, and
mutations in MyBP-C cause cardiac and skeletal muscle disease. The 40 nm
long molecule is composed of 10 or 11 immunoglobulin- or fibronectin-like
domains and is located in up to 9 axial stripes 43 nm apart in each half of
the A-band. To understand MyBP-C function it is important to know its struc-
tural organization in the sarcomere. Several models have been proposed, in
which MyBP-C either wraps around the thick filament, or extends radially
from or longitudinally along the filament (or some combination of these). To
distinguish between these models, we have used immuno-EM of mouse cardiac
myofibrils labeled with antibodies to different domains of MyBP-C to deter-
mine the relative axial positions of the domains. Myofibrils were obtained
from mouse cardiac muscle by homogenizing chemically skinned hearts under
rigor conditions. They were labeled with antibodies specific for the N-terminal
domain, the middle of the molecule, and the C-terminal domain, and observed
by negative stain EM. Labeled myofibrils showed nine stain-excluding stripes
in each half of the A-band. The average distance of each stripe from the middle
of the M-line was measured. All antibodies labeled axially within 10 nm of
each other, at the same axial positions as the unlabeled stripes, suggesting
that the bulk of MyBP-C runs radially or circumferentially. A small axial dif-
ference between the C-terminal and the central and N-terminal antigenic sites
suggests that a short portion of the C-terminus runs longitudinally. Electron to-
mography of muscle sections (Luther et al., PNAS 2011) and 3D reconstruction
of isolated thick filaments (Zoghbi et al., PNAS 2008) support the radial
arrangement.
1579-Pos Board B471
Structural Changes in Myosin Binding Protein C in Different Biochemical
Conditions
Fa-Qing Zhao, Kyounghwan Lee, Roger Craig.
UMass Medical School, Worcester, MA, USA.
Myosin binding protein C (MyBP-C) is an accessory protein of the thick fila-
ments of vertebrate striated muscle. Its function in skeletal muscle is not yet un-
derstood, but it is known tomodulate contractility in the heart. Defects inMyBP-
C lead to both skeletal and cardiacmuscle disease.MyBP-C is an elongatedmol-
ecule consisting primarily of a linear array of 10 (skeletal) or 11 (cardiac) immu-
noglobulin- and fibronectin-like 10 kDa domains. In addition to binding to the
thick filament via its C-terminus, MyBP-C can also interact with myosin
subfragment-2 andwith actin via its N-terminus.MyBP-C is observed in EM im-
ages of sarcomeres as a set of up to nine transverse stripes, 43 nm apart, in each
half of the A-band. Electron tomography of skeletal muscle in the relaxed state
suggests that these stripes are due to extension ofMyBP-C from the surface of the
thick filament to the thin filaments, to which it binds. To investigate whether
MyBP-C might change structurally in different physiological states, we have
carried out experiments on isolated myofibrils and A-segments (A-bands free
of thin filaments) to determine the appearance of the stripes under different bio-
chemical conditions. Preliminary results suggest that in myofibrils (where thin
filaments overlap thick filaments), stripes are present in both relaxed and rigor
states, although they are less prominent in rigor. In A-segments (lacking thin fil-
aments), stripes are common in the relaxed and activated (ATP/high Ca2þ)
states, but weak or absent in rigor. The results are consistent with a model in
which the N-terminus of MyBP-C binds to actin filaments when they are avail-
able, and to myosin subfragment-2 when they are not.
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California Davis, Davis, CA, USA.Autosomal dominant mutations in myosin binding protein C (MYBPC3) ac-
count for up to 30% of myofibrillar mutations causing Hypertrophic Cardiomy-
opathy (HCM). We used SPontaneous Oscillatory Contractions (SPOC) to
compare the performance of isolated cardiomyocytes from heterozygous
MYBPC (þ/-) and homozygous MYBPC (-/-) and wild type (þ/þ) mice.
Our aim is to identify changes in their contractile parameters. SPOC is a phys-
iological state that is intermediate to full contraction and relaxation. The stable
auto-oscillatory properties of SPOC are well suited to precise measurements of
contraction and relaxation.
Preliminary evaluations reveal there is: (1) a progressive prolongation in both
the relative lengthening and shortening periods from MYBPCþ/þ to
MYBPCþ/- and MYBPC-/-; (2) MYBPCþ/- exhibits faster rates of lengthen-
ing than MYBPCþ/þ; (3) MYBPC-/- displays significantly depressed rates of
shortening compared to MYBPCþ/- and
MYBPCþ/þ. These findings suggest sig-
nificant systolic dysfunction in MYBPC-/-
associated with severe hypertrophic re-
modelling. Perhaps, more importantly
MYBPCþ/- exhibits diastolic dysfunction
consistent with previous reports examin-
ing SPOC in human HCM at the 56th
Biophysical Society Meeting. We con-
clude that SPOC can objectively assess
the functional state of heart muscle fibres
in this mouse model.1581-Pos Board B473
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Calcium binding to thin filaments is a major element controlling active force
generation in striated muscles. Recent evidence suggests that processes other
than Ca2þ binding, such as phosphorylation of myosin RLC also controls
contraction of vertebrate striated muscle [1]. Electron Paramagnetic Reso-
nance (EPR) studies using nucleotide-analog spin label probes showed that
dephosphorylated myosin heads are highly ordered in the relaxed fibers
and have very low ATPase activity. This ordered structure of myosin
cross-bridges disappears with the phosphorylation of RLC [2]. The slower
ATPase activity in the dephosphorylated moiety has been defined as
a new super-relaxed state (SRX) [1]. It can be observed in both skeletal
[3] and cardiac muscle fibers [4]. Given the importance of the SRX which
suggests a novel pathway of regulation of skeletal muscle, we aim to
examine the effects of phosphorylation on cross-bridge orientation and
rotational motion. We find that: (1) relaxed cross-bridges are statistically
better ordered in muscle where the RLC is dephosphorylated compared to
phosphorylated RLC; (2) during relaxation, phosphorylated and dephos-
phorylated cross-bridges rotate equally slowly; and (3) during isometric
contraction, phosphorylated cross-bridges rotate considerably faster than de-
phosphorylated ones.
1. Cooke, R. Biophys Rev, 2011. 3(1): p. 33-45.
2. Naber et al. Biophysical Soc 55-th Annual Meeting, 2011: p. 26.
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Rationale: Alterations to the cardiac regulatory light chain (RLC) phosphory-
lation state correlate with many types of cardiac disease including familial hy-
pertrophic cardiomyopathies (FHC’s) and heart failure (HF) post myocardial
infarction (MI). However, little is known regarding the role of RLC
phosphorylation in regulating cardiac contraction mechanics during
shortening. Objective: Determine the mechanical effect of altered cRLC phos-
phorylation on the force-velocity characteristics of cardiac muscle.
